Javier Molina-Méndez FJ

Language: Spanish
References: 11
Page: 226-230
PDF size: 485.50 Kb.

Text Extraction

No abstract

REFERENCES

1. Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995; 92: 2236-44.

2. Arrowsmith JE, Grocott HP, Reves JG, Newman MF. Centralnervous system complications of cardiac surgery. Brit J Anaesth 2000; 84: 378–93.

3. van Dijk D, Keizer AM, Diephuis JC, Durand C, Vos LJ, Hijman R. Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. J Thorac Cardiovasc Surg 2000; 120: 632–9.

4. Korenkov AI, Pahnke J, Frei K, Warzok R, Schroeder HW, Frick R, et al. Treatment with nimodipine or mannitol reducesprogrammed cell death and infarct size following focal cerebralischemia. Neurosurg Rev 2000; 23: 145 50.

5. Suzuki K, Kazui T, Terada H, Umemura K, Ikeda Y, Bashar AH, et al. Experimental study on the protective effects of edaravone against ischemic spinal cord injury. J Thorac Cardiovasc Surg 2005; 130: 1586-92.

6. Amory DW, Grigore A, Amory JK, Gerhardt MA, White WD, Smith PK, et al. Neuroprotection is associated with beta-adrenergicreceptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth 2002; 16: 270–7.

7. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 2002; 22: 1283–96.

8. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane inpatients undergoing coronary surgery with cardiopulmonary Bypass are related to the modalities of its administration. Anesthesiology 2004; 101: 299–310.

9. Ardehali H. Role of the mitochondrial ATP-sensitive K+ channels in cardioprotection. Acta Biochim Pol 2004; 51: 379–90.

10. Kakinohana M, Marsala M, Carter C, Davison JK, Yaksh TL. Neuraxial morphine may trigger transient motor dysfunction after a noninjurious interval of spinal cord ischemia: a clinical and experimental study. Anesthesiology 2003; 98: 862–70.

11. Zheng S, Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003; 118: 99–106.